These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12839314)

  • 1. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
    Raissy HH; Harkins M; Esparham A; Kelly HW
    Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of levalbuterol versus racemic albuterol.
    Quinn C
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S153-7. PubMed ID: 15354680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
    Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
    J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
    Carl JC; Myers TR; Kirchner HL; Kercsmar CM
    J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.
    Qureshi F; Zaritsky A; Welch C; Meadows T; Burke BL
    Ann Emerg Med; 2005 Jul; 46(1):29-36. PubMed ID: 15988423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk versus benefit considerations for the beta(2)-agonists.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
    Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
    Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.